Vibegron
id:
vibegron-173-2420262
title:
Vibegron
text:
Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder. Vibegron is a selective beta-3 adrenergic receptor agonist. The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection. Vibegron was first discovered by scientists at Merck & Co. Inc. and was later developed in Japan by Kyorin Pharmaceutical Co., Ltd, Kissei Pharmaceutical Co., Ltd, and Urovant Sciences. It was app
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Vibegron
date created:
2020-12-23T22:40:44Z
date modified:
2024-09-02T01:26:54Z
main entity:
{"identifier":"Q27283524","url":"https://www.wikidata.org/entity/Q27283524"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b6/Vibegron.svg","width":512,"height":206}
fields total:
13
integrity:
16